Back to trial details

Intake questionnaire

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Applying to Johns Hopkins Kimmel Cancer Center · Baltimore, Maryland

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Metastatic Breast Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Baltimore for study visits?